Cargando…

Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis

Psoriatic arthritis (PsA) is a chronic inflammatory disease characterized by skin and joint involvement. The disease may present with various joint pattern involvement, which sometimes may lead to joint destruction and deformity. Early diagnosis and treatment with disease-modifying anti-rheumatic dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gediz, Fusun, Ugur, Mehmet Can, Turkmen, Meltem, Kobak, Senol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2021
Materias:	Case-Based Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944959/ https://www.ncbi.nlm.nih.gov/pubmed/33707797 http://dx.doi.org/10.5114/reum.2021.102618

Ejemplares similares

Ustekinumab for the treatment of psoriatic arthritis: an update
por: Davari, Parastoo, et al.
Publicado: (2014)

Ustekinumab in the Treatment of Psoriasis and Psoriatic Arthritis
por: Savage, Laura J., et al.
Publicado: (2015)

Characteristics of Turkish patients with elderly onset psoriatic arthritis: A retrospective cohort study
por: Kobak, Senol, et al.
Publicado: (2017)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone, Monica, et al.
Publicado: (2014)

Ustekinumab-induced amelioration of both palmoplantar psoriasis and psoriatic glossitis
por: Tonini, Annalisa, et al.
Publicado: (2019)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, Laura C., et al.
Publicado: (2022)

Serum salusin-α and salusin-β levels in patients with psoriatic arthritis
por: Kobak, Senol, et al.
Publicado: (2022)

Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Koutsompina, Maria-Loukia, et al.
Publicado: (2021)

Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia
por: Soyaltin, Utku Erdem, et al.
Publicado: (2016)

Pembrolizumab-Induced Seronegative Arthritis and Fasciitis in a Patient with Lung Adenocarcinoma
por: Kobak, Senol
Publicado: (2019)

Ustekinumab Treatment and Improvement of Physical Function and Health‐Related Quality of Life in Patients With Psoriatic Arthritis
por: Rahman, Proton, et al.
Publicado: (2016)

Impact of psoriatic arthritis and comorbidities on ustekinumab outcomes in psoriasis: a retrospective, observational BADBIR cohort study
por: Tillett, William, et al.
Publicado: (2023)

Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit
por: Cetintepe, Tugba, et al.
Publicado: (2021)

Secukinumab-induced Raynaud’s phenomenon: first report in the literature
por: Kobak, Senol
Publicado: (2020)

Intravenous Golimumab in Patients with Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis and Subcutaneous Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Extrapolation of Data from Studies in Adults and Adjacent Pediatric Populations
por: Leu, Jocelyn H., et al.
Publicado: (2022)

Digital Vasculitis in a Patient with Rheumatoid Arthritis Responded Well to Adalimumab
por: Kobak, Senol, et al.
Publicado: (2014)

The Frequency of Association of Nail Involvement and Psoriatic Arthritis in Psoriasis Patients
por: Pala, Erdal, et al.
Publicado: (2023)

Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto, Satohiro, et al.
Publicado: (2018)

Psoriatic Arthritis
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis
por: Kawalec, P., et al.
Publicado: (2017)

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
por: Ghosh, Subrata, et al.
Publicado: (2019)

Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
por: Gossec, Laure, et al.
Publicado: (2023)

Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
por: Van Kuijk, Arno W R, et al.
Publicado: (2023)

Multiple Lentigines Arising in Sites of Resolving Psoriatic Plaques after Treatment with Ustekinumab
por: Kim, Jeong Soo, et al.
Publicado: (2018)

Correction to: Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
por: Ghosh, Subrata, et al.
Publicado: (2019)

Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
por: Rahman, Proton, et al.
Publicado: (2020)

Ustekinumab-induced subacute cutaneous lupus
por: Tierney, Emma, et al.
Publicado: (2019)

Ustekinumab-induced fixed drug eruption
por: Hafez, Dhafer M., et al.
Publicado: (2020)

A case of ustekinumab-induced sclerouveitis
por: Godwin, Kristen S., et al.
Publicado: (2022)

Regression of Sarcoidosis during Pregnancy: Case Report and Review of the Literature
por: Kobak, Senol
Publicado: (2020)

The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks’ observation
por: Wcisło-Dziadecka, Dominika, et al.
Publicado: (2021)

Sulfasalazine induced immune thrombocytopenia in a patient with rheumatoid arthritis
por: Narayan, Nehal, et al.
Publicado: (2016)

Chylothorax due to leukemic infiltration in a patient with chronic lymphocytic leukemia
por: Tanrıverdi, Hakan, et al.
Publicado: (2015)

Guselkumab-induced vitiligo in a patient with psoriatic arthritis
por: Martora, Fabrizio, et al.
Publicado: (2023)

Evaluation of Hearing and Outer Hair Cell Function of Cochlea in Patients With Psoriatic Arthritis
por: Akdag, Mehmet, et al.
Publicado: (2015)

SARS-CoV-2 Infection-Induced Necrotising Sarcoid Granulomatosis
por: Koc, Aysu Sinem, et al.
Publicado: (2023)

Hypersensitivity to IV Ustekinumab but Tolerance to Subcutaneous Ustekinumab in a Patient With Crohn's Disease
por: Krugliak Cleveland, Noa, et al.
Publicado: (2020)

Efficacy of ustekinumab in biologic-naïve patients with psoriatic arthritis by prior treatment exposure and disease duration: data from PSUMMIT 1 and PSUMMIT 2
por: McInnes, Iain B, et al.
Publicado: (2019)

Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
por: Smolen, Josef S, et al.
Publicado: (2021)

94. Psoriatic arthritis, rheumatoid arthritis or both?
por: Zhang, Jean, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0rvt0jltdcrba732cijop612ss